Deng, Heping
Deng, Hejun http://orcid.org/0000-0002-9008-0096
Kim, Chiho http://orcid.org/0000-0001-6846-5515
Li, Peng http://orcid.org/0000-0002-7751-1146
Wang, Xudong
Yu, Yonghao http://orcid.org/0000-0001-8414-4666
Qin, Tian http://orcid.org/0000-0001-7225-3224
Funding for this research was provided by:
Welch Foundation (I-2155-20230405, I-2010-20190330, I-1800)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM141088)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS122533)
Article History
Received: 27 December 2022
Accepted: 11 October 2023
First Online: 27 November 2023
Competing interests
: Patent WO 2022/150667 ‘Nimbolide analogs and methods of use thereof’ has been filed on some aspects of the work in this paper, and H.D., H.D., C.K., P.L., Y.Y. and T.Q. are listed as inventors. Y.Y. and T.Q. are co-founders and shareholders of ProteoValent Therapeutics. The other authors declare no competing interests.